Morgan Stanley plans contingent income autocallables tied to Celgene

By Susanna Moon

Chicago, Dec. 19 – Morgan Stanley Finance LLC plans to price contingent income autocallable securities due Dec. 27, 2019 linked to Celgene Corp. stock, according to an FWP filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 9.75% if the stock closes at or above the downside threshold level, 75% of its initial price, on a determination date for that quarter.

The notes will be redeemed at par plus the contingent coupon if the stock closes at or above its initial price on any of the first 11 determination dates.

The payout at maturity will be par plus the contingent quarterly payment unless the stock finishes below the 75% downside threshold level, in which case investors will be fully exposed to any losses.

The agent is Morgan Stanley & Co. LLC.

The notes are guaranteed by Morgan Stanley.

The notes will price on Dec. 23 and settle on Dec. 29.

The Cusip number is 61766F789.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.